Domain EYEION.com for sale! This premium domain is available now at Kadomain.com
It's not too late to turn it all around.View Entire Post ›
According to Instagram, Bieber counts the multitasking formula among her empties.View Entire Post ›
“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.”View Entire Post ›
The Embryolisse Lait-Crème Concentré is a multi-tasking hidden gem of a facial cream.View Entire Post ›
After the model opened up about her experience being diagnosed with type 1 diabetes, we asked experts about the autoimmune condition, the differences between type 1 and type 2 diabetes, and how this diagnosis can change your life.View Entire Post ›
An acupuncturist explains how this scary-looking acupressure mat can help relieve back pain.View Entire Post ›
A new study reveals that both sugar-sweetened beverages (SSBs) and low- or non-sugar-sweetened beverages (LNSSBs) are significantly associated with a higher risk of developing metabolic dysfunction-associated steatotic liver disease (MASLD).
Research led by the University of Michigan's Kresge Hearing Research Institute and the University of Rochester illuminates the mechanisms through which humans can pick out and focus on single sounds in noisy environments.
A nationwide, longitudinal study characterized how physician attrition rates from clinical practice have changed and the factors associated with a differential likelihood of attrition. The study found that the rate of physicians' attrition from clinical practice has increased from 2013 to 2019.
In a quest to develop new antiviral drugs for COVID-19 and other diseases, a collaboration led by scientists at The Wertheim UF Scripps Institute has identified a potential new drug against the virus that causes COVID-19.
Results of a recently published long-term follow-up of the ASAP trial, which was conducted at universities and clinics across Germany, show that the genetic risk of disease, not remission status, determines overall survival of patients with high-risk acute myeloid leukemia (AML) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Furthermore, there is no benefit of remission induction with standard salvage chemotherapy prior to allo-HSCT.
Invasive lung squamous cell carcinoma (LUSC) accounts for approximately one-quarter of all lung cancers, but therapeutic options for LUSC remain limited, primarily due to the absence of well-defined, targetable molecular alterations. Therefore, histopathologic features are increasingly being explored as tools to enhance prognostic accuracy and guide treatment decisions.
The inhalers people depend on to breathe are also warming the planet, producing annual emissions equivalent to more than half a million cars in the United States alone, researchers said Monday in a major new study.
The Centers for Disease Control and Prevention adopted recommendations by a new group of vaccine advisers, and stopped recommending COVID-19 shots for anyone—leaving the choice up to patients.
Despite progress in past decades to reduce the burden of cardiovascular disease (CVD), it remains the leading cause of death in the U.S. and worldwide. Data within the past 10 years indicate deceleration and reversal of declines in CVD morbidity and mortality. These trends may be further worsened by the prevalence of low heart health, particularly among young adults.
Generalized anxiety disorder affects 1 in 20 U.S. adults. Those with serious symptoms may isolate themselves to the point where they rarely leave their home and are unable to work and build meaningful relationships. Standard medications may make little difference.
Neurons produced from frontotemporal dementia patients' skin biopsies using modern stem cell technology recapitulate the synaptic loss and dysfunction detected in the patients' brains, a new study from the University of Eastern Finland shows.
The U.S. Food and Drug Administration (FDA) is reviewing whether to change the warning label on hormone replacement therapy (HRT) drugs used to treat menopause symptoms, a move many experts say is long overdue.
A new method of taking microscopic images of a live mouse's retina through the eye allows researchers to record the reaction of brain cells to disease and treatment. The Kobe University development is more easily applicable than previous methods and promises to advance research on and treatment of vision-related diseases.